BusinessOcera Therapeutics Reports Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 1, 2017, 8:05 PM UTC
BusinessGalectin Therapeutics Announces Important Milestones towards Completion of NASH CX TrialBy Nasdaq OMXJun 13, 2017, 12:30 PM UTC
BusinessOcera Therapeutics to Host KOL Conference Call on Hepatic Encephalopathy and Other Complications of Liver Disease on Friday, June 2By Nasdaq OMXMay 26, 2017, 1:05 PM UTC
BusinessOcera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical UpdateBy Nasdaq OMXMay 9, 2017, 8:09 PM UTC
BusinessOcera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical UpdateBy Nasdaq OMXMay 9, 2017, 8:09 PM UTC
BusinessOcera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical UpdateBy Nasdaq OMXMay 9, 2017, 8:09 PM UTC
BusinessOcera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical UpdateBy Nasdaq OMXMay 9, 2017, 8:09 PM UTC
BusinessOcera Therapeutics to Report First Quarter 2017 Financial Results and Provide Clinical Update on May 9, 2017By Nasdaq OMXMay 3, 2017, 8:05 PM UTC
